Compounding Services

Baxter provide cytotoxic compounding services from 4 sites in the UK, 3 Joint Ventures with the NHS at Mount Vernon, The Christie and Oxford and one compounding unit at our manufacturing plant in Thetford, Norfolk.

 

Baxter has over 21 years expertise in aseptic manufacture and significant experience in assisting with the establishment of Pharmacy Services.

 

The preparation of these products is carried out under aseptic conditions, and the facilities are licensed by the Department of Health for repackaging by reconstitution or dilution of Parenteral Cytotoxic Agents ready for administration as requested by hospitals.

 

The facilities are also certified to the Quality Systems ISO9001-2000

 

This service aims to address several issues faced by the NHS, for example: doses on hand to reduce waiting times in clinic and ability to outsource compounding to ease pressure on pharmacy compounding facilities.

Baxter's Ready to Use Chemotherapy range used either in combination with the Dose Banding or Dose Rounding concept offers a number of quantifiable advantages.

 

A single syringe or combination of syringes will enable you to deliver within plus or minus 5% of the prescribed dose based on Body Surface Area (BSA) calculations. The syringes can be pre-ordered in batches from a defined list of available drugs and doses. Dose rounding or commonly used doses can also be batch prepared to provide stock for pharmacy or the clinic in a range of delivery devices.

Baxter Healthcare operates a Patient Specific Chemotherapy Reconstitution Service from our licensed compounding facilities. The products can be manufactured in a wide range of presentations including Viaflex® or Viaflo® containers, syringes, Minibags or Infusors.

Baxter Heathcare provides IV aseptic compounding services to the highest standards from 4 UK units. Chemotherapy, antiobiotics, antivirals, and parenteral nutrition admixtures can be prepared under aseptic conditions using specialist equipment and delivered to the hospital pharmacist. The service is backed by comprehensive stability and compatability data produced by Baxter's R&D team.

Baxter Healthcare Ltd. can compound an extensive range of parenteral nutrition formulations to meet routine or individual patient requirements. Our manufacturing facility has over a decade of compounding experience during which time comprehensive testing has been carried out on a wide range of admixtures. All mixtures are presented under strict aseptic conditions undera Manufacturer´s ´Specials´ licence. Our facilities meet ISO 9001-2000 quality standards.

 

Compounded admixtures are subject to stringent Process Control and Quality Assurance procedures to ensure the quality of the final product. Each step of the process is validated and approved to Corporate Statutory Guidelines with patient safety and customer requirements in mind.

 

Admixtures can be provided in EVA or oxygen barrier (multilayer) bags for adult, paediatric, and neonatal patients. Special requirements can be agreed with individual customers.